Surgery

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Profiles

No photo of Gabor Abis

Gabor Abis

Person: Academic

20122019
No photo of Marjolein Ankersmit

Marjolein Ankersmit

Person: Academic

20112019
No photo of Kaoutar Azijli

Kaoutar Azijli

Person: Academic

20172017

Research Output 1981 2020

Health-Related Quality of Life Is Decreased After Necrotizing Soft-Tissue Infections

Suijker, J., de Vries, A., de Jong, V. M., Schepers, T., Ponsen, K. J. & Halm, J. A., 1 Jan 2020, In : Journal of Surgical Research. 245, p. 516-522

Research output: Contribution to journal › Article › Academic › peer-review

269Cardiac magnetic resonance for evaluating non-culprit lesions after acute myocardial infarction: a comparison with fractional flow reserve

Everaars, H., Van Der Hoeven, N. W., Janssens, G. N., Van Leeuwen, M. A., Van Loon, R. B., Demirkiran, A., Hofman, M. B. M., Van Der Geest, R. J., Van De Ven, P. M., Gotte, M. J., Van Rossum, A. C., Van Royen, N. & Nijveldt, R., 1 Jun 2019, In : European Heart Journal-Cardiovascular Imaging. 20, Supplement_2

Research output: Contribution to journal › Article › Academic › peer-review

Abduction in Proximal Hamstring Tendon Avulsion Injury Mechanism: A Report on 3 Athletes

van der Made, A. D., Peters, R. W., Verheul, C., Maas, M. & Kerkhoffs, G. M., 2019, In : Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine. 29, 6, p. e76-e79

Research output: Contribution to journal › Article › Academic › peer-review

Prizes

Are anti-EGFR monoclonal antibodies the magic bullets that remove circulating tumor cells in patients with non-small cell lung cancer (NSCLC)?

Marjolein van Egmond (Recipient), 2018

Prize

Neutrophils as potential targets to prevent tissue damage in chronic inflammation and autoim-munity

Marjolein van Egmond (Recipient), 2018

Prize

Novel Immunotherapies to treat cancer

Marjolein van Egmond (Recipient), 2018

Prize

Activities 2016 2018

‘Immunoglobulin A; Trojan horse or magic bullet?’

Marjolein van Egmond (Keynote speaker)
21 Apr 2018

Activity: Talk or presentation › Invited talk

European Phagocyte Group (External organisation)

M van Egmond (Member)
2018

Activity: Membership › Membership of committee

‘Translating antibody – effector cell cross-talk to immunotherapy’.

Marjolein van Egmond (Invited speaker)
25 Feb 2018 → 2 Mar 2018

Activity: Talk or presentation › Invited talk

Press / Media

Biowetenschappen en maatschappij: Ons Afweersysteem: Hoeder, mediator en verrader Immunologie

Marjolein van Egmond

03/09/2018

1 media contribution

Press/Media: Public Engagement Activities

Libelle article: Feiten & Fabels over kanker

Marjolein van Egmond

08/08/2018

1 media contribution

Press/Media: Public Engagement Activities